Here you will find a list of Philanthropy Impact members (denoted by background colours) as well as resource organisations/umbrella bodies, for example EVPA (with clear backgrounds).
Founded in Bangladesh and now working in eleven countries, we are by some measures the largest non-governmental organisation in the world, an innovator in poverty eradication and a social enterprise offering sustainable pathways out of poverty. Demonstrating the power of a holistic, community-based approach and best known for the scale of our programmes we have created opportunities for 135 million people, mostly women, to create lasting change.
Poor communities are crucial actors and change makers in development and not passive recipients of aid. Working together we design programmes that promote social inclusion through microfinance, education, healthcare, agriculture, livelihood support, legal aid services, community empowerment and profit making social enterprises which feedback into development and take a triple bottom line approach.
BRAC UK works as part of the international BRAC family to raise awareness and funds for our low cost, high impact approach. Developing partnerships in Europe with non-governmental organisations, academics, research institutes, the private sector and governments.
Cancer Research UK
Fondazione Lang Italia
- Advisory services
- Educational activities
- Roundtables and events for discussion & confrontation
Leonard Cheshire Disability
Macmillan Cancer Support
Macmillan Cancer Support provide practical, medical and financial support and push for better cancer care.
William Harvey Research Foundation
William Harvey Research addresses areas of unmet need in pharmacology and the life sciences, with a focus on early-stage research in cardiovascular disease, endocrine disorders, genomics and inflammation.
We exist because funding is limited for early-stage research: very few charities focus on this. Our research addresses many targets (for common and for rare diseases) where there is at present little or no effective treatment.
Statistics that put our research in perspective include the following: 60% of people over 65 in the UK suffer from heart disease; over 6000 patients are waiting to receive organ transplants, and these usually last on 10-15 years; 350,000 children’s lives are debilitated through heart conditions.
Innovative research at WHR is focussed on the advancement of knowledge and the development of new treatments, with the aim of improving these statistics.
Our focus on early-stage, pioneering research is performed at world-leading pharmacology centre, the William Harvey Research Institute. We advance medical knowledge, increase success in clinical trials, and create the potential for new treatments.
WHR’s robust financial model ensures 100% of all donations are used entirely to support research.
William Harvey Research comprises the William Harvey Research Foundation (the charitable arm), William Harvey Research Institute, and William Harvey Research Limited.